BioCentury
ARTICLE | Financial News

Immunovaccine completes private placement

September 1, 2014 7:00 AM UTC

Immunovaccine Inc. (TSX-V:IMV), Halifax, Nova Scotia Business: Cancer, Infectious Date completed: 2014-08-26 Type: Private placement Raised: C$2 million ($1.8 million) Shares: 2.2 million Price: C$0.9...